Anesthetic Cost Analysis With Desflurane in Automated Gas Control Mode

Inonu University

Status: Completed

Conditions: Safety Issues

Study type: Observational

Funder types: Other

Identifiers

NCT03465475

Inonu uni

Details and patient eligibility

About

Inhalation agents constitute the major part of anesthetic drug costs (20% - 25%) and a significant portion of the applied inhalation agents are thrown into the atmosphere through the waste gas system without being absorbed by the patient. The amount of waste gas is directly correlated to the fresh gas flow (FGF). Reducing the TGA during general anesthesia reduces the consumption of inhalant agents and contributes to the reduction of greenhouse gas pollution. Risks such as hypoxia, hypercapnia, inadequate depth of anesthesia and potential toxic gas accumulation were associated with low flow anesthesia, but the patient was provided with adequate safety by following pulse oximetry, capnography, FiO2 and anesthetic gas analysis. We aimed to perform anesthetic cost analysis and patient security in automated gas control mode (AGC).

Full description

After the ethical approvel 60 adult patients scheduled for hepatectomy will be taken to study. Patients will be monitored after they are taken to the operating room (ECG, NIBP, SpO2, Body Temp, BIS, NIRS, PVI, PI, ORI). After the anesthesia induction and tarakeal entubation, first twenty patient will take 300 mL fresh gas flow with AGC mode (group 1), Second twenty patient will take 600 mL fresh gas flow with AGC mode (group 2), third twenty patient will take 600 mL fresh gas flow with manually. Hemodynamic and gas consumption data will be recorded. An operating room will be reserved for this study.

Enrollment: 60 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult patients undergoing hepatectomy with general anesthesia

Exclusion criteria

• Essential data missing
• Patient participating in other research projects
• Drug allergy
• Anesthetic complication story

Trial design

60 participants in 3 patient groups

Group 1

Description:

The patient who receive 300 mL fresh gas flow with AGC mode during the general anesthesia

Group 2

Description:

The patient who receive 600 mL fresh gas flow with AGC mode during the general anesthesia

Group 3

Description:

The patient who receive 600 mL fresh gas flow with manuelly during the general anesthesia